Cayman Pharma s.r.o

  • Cayman Pharma s.r.o. Building | Neratovice, CZ
About Cayman Pharma s.r.o

Cayman Pharma is the world’s most reliable source of prostaglandin Active Pharmaceutical Ingredients (APIs) using its own patented route to manufacture APIs for erectile dysfunction, ophthalmic, veterinary, vascular, and psychedelic applications. Cayman Pharma has an excellent track record and an outstanding record of regulatory compliance. Together with Cayman Chemical Company, Cayman Pharma represents the accumulation of almost 60 years of experience with prostaglandin synthesis.

Certifications
  • CZ
  • 2015
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator
Primary activities
Generic APIs producer
Contact info
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Products from Cayman Pharma s.r.o (5)

  • CGMP (+)-Cloprostenol (sodium salt)

    Product CGMP (+)-Cloprostenol (sodium salt)

    (+)-Cloprostenol is the active enantiomer of Cloprostenol. Cloprostenol is used in veterinary medicine as a luteolytic agent for the induction of estrus and the treatment of reproductive disorders in cattle, swine, and horses. The ASMF for (+)-Cloprostenol (sodium salt) is on file in several EU member states.
  • CGMP Alprostadil

    Product CGMP Alprostadil

    Alprostadil is a vasodilator, and finds clinical use in treating erectile dysfunction, in improving blood flow in peripheral vascular disease, and in maintaining coronary circulation in neonates with vascular anomalies. The DMF for Alprostadil is on file with the US FDA, Canada, India, in many EU member st...
  • CGMP Bimatoprost

    Product CGMP Bimatoprost

    Bimatoprost is a potent FP receptor agonist that finds clinical use as an ocular hypotensive agent for the treatment of glaucoma. The DMF is on file with the US FDA, Canada, and in several EU member states.
  • CGMP Epoprostenol (sodium salt)

    Product CGMP Epoprostenol (sodium salt)

    Epoprostenol is a potent vasodilator and antiplatelet substance with a very short physiologic half-life. It is used for the treatment of pulmonary hypertension. The DMF for Epoprostenol Sodium Salt is on file with the US FDA, Canada, Japan, Australia, and several EU member states.
  • CGMP (±)-Cloprostenol (sodium salt) 

    Product CGMP (±)-Cloprostenol (sodium salt) 

    Cloprostenol is used in veterinary medicine as a luteolytic agent for the induction of estrus and the treatment of reproductive disorders in cattle, swine, and horses. (±)-Cloprostenol sodium salt is manufactured at Cayman Pharma, our Czech subsidiary. GMP material, which conforms to the USP and BVP Monogr...

Cayman Pharma s.r.o Resources (2)

  • News Cayman Chemical Receives CEP for Latanoprost API from EDQM

    ANN ARBOR, MI, SEPTEMBER 12, 2023—Cayman Chemical, a world leader in the manufacture of prostaglandins for both research use and as active pharmaceutical ingredients (APIs), has been granted a Certification of Suitability to the monographs of the European Pharmacopoeia (CEP) by the European Directorate for the Quality of Medicines and HealthCare (EDQM) for its latanoprost API, effective August 28th, 2023. Cayman Chemical is the first company in the USA to receive a CEP for latanoprost.
  • Brochure API Manufacturing

    Learn more about the importance of process understanding and Cayman's commercial API production